European Primary Care Cardiovascular Society

Surprising result: Very high levels of HDL-c are associated with increased risk of CV events

Aug. 30, 2018 - Dr. Mark Philip Allard-Ratick, Atlanta, GA, USA

Association higher healthy diet score and lower risk of mortality and CV events across the globe

Aug. 28, 2018 - Dr. Andrew Mente, Hamilton, ONT, Canada

CV safety with weight loss agent in high-risk overweight or obese patients

Aug. 26, 2018 - Dr. Erin Bohula, Boston, MA, US

No overall benefit with aspirin in a primary prevention setting of diabetes patients

Aug. 27, 2018 - Prof. Jane Armitage, Oxford, UK

Omega-3 fatty acid supplements do not result in CV benefits

Aug. 26, 2018 - Dr Louise Bowman, Oxford, UK

Hypertension - Can we agree on diagnostic and therapeutic thresholds?

Mar. 16, 2018 - EPCCS 2018, Barcelona, Spain - Prof. Richard McManus, prof. Richard Hobbs and prof. Christos Lionis

Complexities of managing heart failure

Mar. 16, 2018 - EPCCS 2018, Barcelona, Spain - Dr. Clare Taylor, Dr. Nuria Farré and Dr. Frans Rutten
Preventing Cardiovascular Disease in Patients with T2DM - How to apply novel outcome data with GLP-1 RA to clinical practice (3/3)

Practical management of cardiovascular risk: Lessons from latest diabetes trials

July 17, 2018 - Prof. Lars Rydén - Stockholm, Sweden
Preventing Cardiovascular Disease in Patients with T2DM - How to apply novel outcome data with GLP-1 RA to clinical practice (2/3)

Diabetes: How to reduce risk from a cardiovascular perspective?

July 12, 2018 - Prof. Diederick Grobbee - Utrecht, The Netherlands

Lipids and food

July 11, 2018 - Prof. David Marais - Cape Town, South Africa

The cardiovascular challenge for primary care in diabetes

July 10, 2018 - Prof. Richard Hobbs - Oxford, UK

Spain - EPCCS Introduction

June 19, 2018

Lower Extremity Artery Disease: a neglected major CV disease: Diagnosis and clinical management in primary care

Mar. 15, 2018 - EPCCS 2018, Barcelona, Spain - Dr. Rafel Ramos (Girona, Spain)

Lipid lowering: the evidence, the guidelines, the clinical reality

Mar. 17, 2018 - EPCCS 2018, Barcelona, Spain - Dr. Monika Hollander, prof. Frank Visseren, dr. Jan Oltrogge

Management of CV risk that comes with T2DM in light of novel treatment options

Mar. 15, 2018 - EPCCS 2018, Barcelona, Spain - Dr. Carlos Brotons, prof. Xavier Cos, prof. Richard Hobbs

Treatment of high-risk ACS patients may change based on ODYSSEY OUTCOMES study results

Mar. 10, 2018 - ACC 2018, Orlando, FL, USA - Dr. Valentin Fuster, New York, NY, USA

Pharmacist intervention in American 'black barbershops' effective at lowering BP

Mar. 12, 2018 - ACC 2018, Orlando, FL, USA - Dr. Ronald Victor, MD - Los Angeles, CA, USA

PCSK9 inhibitor has very good benefit-to-risk profile in high risk ACS patients in ODYSSEY OUTCOMES trial

Mar. 10, 2018 - ACC 2018, Orlando, FL, USA - Prof. Gabriel Steg - Paris, France

Striking results for weight reduction in T2DM in primary care based program

Dec. 18, 2017 - IDF 2017 - Abu Dhabi, UAE - Prof Naveed Sattar, MD - Glasgow, UK

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

Nov. 20, 2017 - AHA 2017 - Anaheim, CA, USA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

Long-term CV benefits with intervention for BP and cholesterol in hypertensive patients

Sep. 26, 2018 - Gupta A et al. - The Lancet 2018

BP lowering with amlodipine and lipid lowering with atorvastatin still resulted in lower rates of stroke and CV death in hypertensive patients after more than a decade, as the results of a long-term follow-up of data from the ASCOT trial show.

Diastolic BP level is important to limit CV risk, even at optimal systolic BP

Sep. 25, 2018 - Boehm M et al. - Eur Heart J 2018

In patients with a systolic BP between 120 and <140 mmHg, a diastolic BP between 70 and <80 mmHg was associated with a lower risk of adverse outcomes as compared to lower and higher DBP.

General practitioners minimally involve their patients in shared-decision making

Sep. 18, 2018 - Meijers MC et al. - Family Practice, 2018

An observational study showed longer consultations with minimal shared-decision making behavior by GPs during daily practice in 2015 compared with 2007, with less shared-decision making behavior in older patients.

New ESC guidelines on management of CVD during pregnancy

Sep. 14, 2018 - news

The new guidelines on management of CVD during pregnancy consider new evidence on diagnostic techniques, risk assessment and drug therapy that became available since the 2012 edition.

Increased mortality in patients with delayed BP control after first diagnosis

Sep. 12, 2018 - Martın-Fernandez M et al. - J Hypertension 2018

One third of patients with newly diagnosed hypertension in this study required more than 125 days for their BP to be controlled. A longer delay in BP control was independently associated with all-cause mortality.

Cardiorespiratory fitness related to longevity in middle-aged men without CVD

Sep. 12, 2018 - Clausen JSR et al. - JACC 2018

The prospective Copenhagen Male study followed men for 46 years and showed that cardiorespiratory fitness is dose-dependently associated with longevity in middle-aged men without CVD.

ESC Debate | Should hypertension be redefined?

ESC 2018 - debates

ESC 2018 In this debate, the different viewpoints supporting the European and American Guidelines on Hypertension were fiercely defended, although overlap prevails.

Surprising result: Very high levels of HDL-c are associated with increased risk of CV events

Aug. 30, 2018 - Dr. Mark Philip Allard-Ratick, Atlanta, GA, USA
Dr Allard-Ratick tells about the surprising result that HDL-C levels >60 mg/dl (1.5 mmol/L) were associated with a nearly two-fold increase in the risk of CV death or MI in adults with CV disease.

ESC 2018 Dr Allard-Ratick tells about the surprising result that HDL-C levels >60 mg/dl (1.5 mmol/L) were associated with a nearly two-fold increase in the risk of CV death or MI in adults with CV disease.

Association higher healthy diet score and lower risk of mortality and CV events across the globe

Aug. 28, 2018 - Dr. Andrew Mente, Hamilton, ONT, Canada
In an analysis of four large global studies, higher healthy diet score was related to a lower risk of mortality, MI and stroke. Dr. Mente discusses how the healthy diet score is calculated and talks about the results of these four studies.

ESC 2018 In an analysis of four large global studies, higher healthy diet score was related to a lower risk of mortality, MI and stroke. Dr. Mente discusses how the healthy diet score is calculated and talks about the results of these four studies.

CV safety with weight loss agent in high-risk overweight or obese patients

Aug. 26, 2018 - Dr. Erin Bohula, Boston, MA, US
In overweight or obese patients with CVD or diabetes with one CV risk factor, lorcaserin demonstrated to be safe with respect to CV outcomes. Dr. Bohula discussed the implications of the CAMELLIA-TIMI 61 trial.

ESC 2018 In overweight or obese patients with CVD or diabetes with one CV risk factor, lorcaserin demonstrated to be safe with respect to CV outcomes. Dr. Bohula discussed the implications of the CAMELLIA-TIMI 61 trial.

No overall benefit with aspirin in a primary prevention setting of diabetes patients

Aug. 27, 2018 - Prof. Jane Armitage, Oxford, UK
Although aspirin resulted in a reduction of CV events in a primary prevention setting of diabetes patients, this CV benefit was counterbalanced by an increase in bleeding.

ESC 2018 Although aspirin resulted in a reduction of CV events in a primary prevention setting of diabetes patients, this CV benefit was counterbalanced by an increase in bleeding.

Omega-3 fatty acid supplements do not result in CV benefits

Aug. 26, 2018 - Dr Louise Bowman, Oxford, UK
Use of omega-3 fatty acid supplements did not result in reduction of CV outcomes in the ASCEND trial, a large, randomized, long-term trial of diabetes patients.

ESC 2018 Use of omega-3 fatty acid supplements did not result in reduction of CV outcomes in the ASCEND trial, a large, randomized, long-term trial of diabetes patients.